Field Studies of an Attenuated Venezuelan Equine Encephalomyelitis Vaccine (Strain TC-83)
AUTOR(ES)
Eddy, Gerald A.
RESUMO
A series of field studies using strain TC-83 attenuated Venezuelan equine encephalomyelitis vaccine in horses was made to determine the rate of seroconversions, the postvaccination viremia, and the possibility of adverse reactions to the vaccine. The rate of seroconversions varied from 50% in one study to 91 and 100% in two others. The highest level of viremia measured was 7 × 103 to 8 × 103 plaqueforming units per ml. No adverse reactions to the vaccine were observed in any horses, including 42 pregnant mares and their resulting foals.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=422340Documentos Relacionados
- Experimental Infection of Horses with an Attenuated Venezuelan Equine Encephalomyelitis Vaccine (Strain TC-83)
- Inactivated Venezuelan Equine Encephalomyelitis Vaccine Prepared from Attenuated (TC-83 Strain) Virus
- Improved method for production of attenuated Venezuelan equine encephalomyelitis (TC-83 strain) vaccine.
- Stability of Live Attenuated Venezuelan Equine Encephalitis Vaccine
- Homogeneity of Venezuelan Encephalitis Virion Populations of Hamster-Virulent and Benign Strains, Including the Attenuated TC83 Vaccine